NovoCure Limited (NVCR) Debt Components
- 2025-12-31: Convertible Notes Payable, CurrentUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $195.05M; Long-term Debt and Lease Obligation, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m).
- 2025-09-30: Convertible Notes Payable, CurrentUSD $560.62M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term Debt and Lease Obligation, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m).
- 2025-06-30: Convertible Notes Payable, CurrentUSD $559.79M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term Debt and Lease Obligation, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m).
- 2025-03-31: Convertible Notes Payable, CurrentUSD $558.97M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term Debt and Lease Obligation, CurrentUSD (m); Long-term Debt and Lease ObligationUSD (m).
NovoCure Limited Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt and Lease Obligation, Current USD | Long-term Debt and Lease Obligation USD | Long-term Debt USD | Long-term Debt and Lease Obligation, Including Current Maturities USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two USD | Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 | $195.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $560.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $559.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $558.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $558.16M | $97.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $557.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $569.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $568.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $0.00 | $568.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $567.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $567.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $566.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $565.51M | (m) | $72.00K | $565.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $564.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $563.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $563.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $562.22M | (m) | $12.00K | $562.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $561.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $560.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $559.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $429.90M | (m) | $40.00K | $429.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $149.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $149.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $149.42M | (m) | $66.00K | $149.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $149.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $149.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $149.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $149.27M | (m) | $94.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | $31.00K | (m) | (m) | $125.00K | (m) | $12.00K | $27.00K | $26.00K | $29.00K | $31.00K |
| 2018-09-30 | (m) | $149.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $149.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $149.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $97.34M | (m) | $128.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $32.00K | (m) | (m) | $160.00K | $12.00K | $27.00K | $26.00K | $29.00K | $34.00K | $32.00K |
| 2017-09-30 | (m) | $97.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $96.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $96.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $96.23M | (m) | $193.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $70.00K | (m) | (m) | $263.00K | $39.00K | $26.00K | $24.00K | $27.00K | $77.00K | $70.00K |
| 2016-09-30 | (m) | $95.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $23.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $23.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $23.10M | (m) | $254.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $63.00K | (m) | (m) | $317.00K | $65.00K | $24.00K | $23.00K | $73.00K | $69.00K | $63.00K |
| 2015-09-30 | (m) | $24.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $0.00 | (m) | $321.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |